2003 Chapter 961

961.18(7)(n) (n) Mibolerone;

961.18(7)(o) (o) Nandrolone;

961.18(7)(p) (p) Norethandrolone;

961.18(7)(q) (q) Oxandrolone;

961.18(7)(r) (r) Oxymesterone;

961.18(7)(s) (s) Oxymetholone;

961.18(7)(t) (t) Stanozolol;

961.18(7)(u) (u) Testolactone;

961.18(7)(v) (v) Testosterone;

961.18(7)(w) (w) Trenbolone.

961.18 History History: 1971 c. 219; 1981 c. 6; 1981 c. 206 ss. 32 to 40, 57; CSB 2.19, 2.21; 1995 a. 448 ss. 181 to 200, 475, 476; Stats. 1995 s. 961.18; 1997 a. 220; CSB 2.25; CSB 2.29; CSB 2.30.

961.18 Note NOTE: See 1993-94 Statutes for notes on actions by controlled substances board under s. 161.11 (1), 1993 Stats.

961.19 961.19  Schedule IV tests.

961.19(1m) (1m) The controlled substances board shall add a substance to schedule IV upon finding that:

961.19(1m)(a) (a) The substance has a low potential for abuse relative to substances included in schedule III;

961.19(1m)(b) (b) The substance has currently accepted medical use in treatment in the United States; and

961.19(1m)(c) (c) Abuse of the substance may lead to limited physical dependence or psychological dependence relative to the substances included in schedule III.

961.19(2m) (2m) The controlled substances board may add a substance to schedule IV without making the findings required under sub. (1m) if the substance is controlled under schedule IV of 21 USC 812 (c) by a federal agency as the result of an international treaty, convention or protocol.

961.19 History History: 1971 c. 219; 1995 a. 448 ss. 201, 202, 477; Stats. 1995 s. 961.19.

961.20 961.20  Schedule IV. Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in schedule IV:

961.20(2) (2) Depressants. Any material, compound, mixture or preparation which contains any quantity of any of the following substances having a depressant effect on the central nervous system, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:

961.20(2)(a) (a) Alprazolam;

961.20(2)(am) (am) Barbital;

961.20(2)(ar) (ar) Bromazepam;

961.20(2)(av) (av) Camazepam;

961.20(2)(b) (b) Chloral betaine;

961.20(2)(c) (c) Chloral hydrate;

961.20(2)(cd) (cd) Clobazam;

961.20(2)(cg) (cg) Clotiazepam;

961.20(2)(cm) (cm) Chlordiazepoxide;

961.20(2)(cn) (cn) Clonazepam;

961.20(2)(co) (co) Cloxazolam;

961.20(2)(cp) (cp) Clorazepate;

961.20(2)(cq) (cq) Delorazepam;

961.20(2)(cr) (cr) Diazepam;

961.20(2)(cs) (cs) Dichloralphenazone;

961.20(2)(cu) (cu) Estazolam;

961.20(2)(d) (d) Ethchlorvynol;

961.20(2)(e) (e) Ethinamate;

961.20(2)(ed) (ed) Ethyl loflazepate;

961.20(2)(eg) (eg) Fludiazepam;

961.20(2)(ej) (ej) Flunitrazepam;

961.20(2)(em) (em) Flurazepam;

961.20(2)(eo) (eo) Halazepam;

961.20(2)(ep) (ep) Haloxazolam;

961.20(2)(eq) (eq) Ketazolam;

961.20(2)(er) (er) Lorazepam;

961.20(2)(es) (es) Loprazolam;

961.20(2)(eu) (eu) Lormetazepam;

961.20(2)(ew) (ew) Mebutamate;

961.20(2)(ey) (ey) Medazepam;

961.20(2)(f) (f) Methohexital;

961.20(2)(g) (g) Meprobamate;

961.20(2)(h) (h) Methylphenobarbital, which is also called mephobarbital;

961.20(2)(hg) (hg) Midazolam;

961.20(2)(hh) (hh) Nimetazepam;

961.20(2)(hj) (hj) Nitrazepam;

961.20(2)(hk) (hk) Nordiazepam;

961.20(2)(hm) (hm) Oxazepam;

961.20(2)(hr) (hr) Oxazolam;

961.20(2)(j) (j) Paraldehyde;

961.20(2)(k) (k) Petrichloral;

961.20(2)(m) (m) Phenobarbital;

961.20(2)(md) (md) Pinazepam;

961.20(2)(mg) (mg) Prazepam;

961.20(2)(mm) (mm) Quazepam;

961.20(2)(n) (n) Temazepam;

961.20(2)(ng) (ng) Tetrazepam;

961.20(2)(nm) (nm) Triazolam;

961.20(2)(o) (o) Zaleplon;

961.20(2)(p) (p) Zolpidem.

961.20(2m) (2m) Stimulants. Any material, compound, mixture, or preparation which contains any quantity of any of the following substances having a stimulant effect on the central nervous system, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:

961.20(2m)(a) (a) Diethylpropion.

961.20(2m)(ad) (ad) Cathine.

961.20(2m)(ag) (ag) N,N-dimethyl-1,2-diphenylethylamine, commonly known as "SPA".

961.20(2m)(ak) (ak) Ephedrine, if ephedrine is the only active medicinal ingredient or if there are only therapeutically insignificant quantities of another active medicinal ingredient.

961.20(2m)(ar) (ar) Fencamfamine.

961.20(2m)(at) (at) Fenproporex.

961.20(2m)(bm) (bm) Mazindol.

961.20(2m)(br) (br) Mefenorex.

961.20(2m)(bu) (bu) Modafinil.

961.20(2m)(c) (c) Pemoline, including its organometallic complexes and chelates.

961.20(2m)(d) (d) Phentermine.

961.20(2m)(e) (e) Pipradrol.

961.20(2m)(f) (f) Sibutramine.

961.20(3) (3) Narcotic drugs containing nonnarcotic active medicinal ingredients. Any compound, mixture or preparation containing any of the following narcotic drugs or their salts, isomers or salts of isomers, in limited quantities as set forth below, calculated as the free anhydrous base or alkaloid, which also contains one or more nonnarcotic, active medicinal ingredients in sufficient proportion to confer upon the compound, mixture or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:

961.20(3)(a) (a) Not more than 1.0 milligrams of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit.

961.20(4) (4) Other substances. Any material, compound, mixture or preparation which contains any quantity of any of the following substances or their salts:

961.20(4)(a) (a) Dextropropoxyphene (Alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane).